Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alginos in Laryngopharyngeal Reflux
NCT01450748Phase 3Completed
- Sponsor
- TTY Biopharm Company Limited
- Start
- Oct 2011
- Primary completion
- Mar 2015
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of Alginos in laryngopharyngeal reflux (LPR), sponsored by TTY Biopharm Company Limited. Started Oct 2011; status: completed.
02
Drugs
Alginos
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on NCT01450748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01450748.